Press Releases
 
Oral Anti-diabetes Drugs Market Scope and Opportunities Analysis 2017 - 2025

, 27 March 2019 -- Diabetes is a chronic disease that occurs when the body cannot effectively use the produced insulin or the pancreas does not produce sufficient insulin. The pancreas is an organ that sits behind the stomach and releases hormones into the digestive system. Diabetes is categorized by increased levels of blood glucose, which can cause severe damage to blood vessels, heart, kidneys, nerves, and eyes.

Read Report Overview:
https://www.transparencymarketresearch.com/oral-anti-diabetes-drugs-market.html

Diabetes is also called hyperglycemia or raised blood sugar. Insulin is a hormone that regulates the blood sugar level in body. Continuous increase in blood sugar leads to diabetes. Uncontrollable diabetes can damage the nervous system and other body systems.

Diabetes is of two types: type 1 and type 2. Type 1 diabetes, also known as juvenile diabetes or insulin-dependent diabetes, arises when the immune system misguidedly attacks and kills the beta cells of the pancreas. In type 1 diabetes, little or no insulin is released into the body, owing to this sugar builds up in the blood instead of being used as energy. Type 1 diabetes is rare, and only 10% of people with diabetes have type 1 diabetes. It commonly occurs in childhood or adolescence. Type 2 diabetes arises when the body cannot appropriately use the insulin that is released or does not make enough insulin. As a consequence, sugar builds up in the blood instead of being used as energy. About 90% of people with diabetes have type 2 diabetes.

Oral Anti-diabetes Drugs Market: Dynamics

Increasing obese population and changing lifestyle are the factors projected to boost market growth. Advancements in technologies and reimbursement for medicines are anticipated to fuel the growth of the oral anti-diabetes drug market in the next few years. Moreover, rising incidence of diabetes is expected to increase demand for oral anti-diabetes drugs. However, ongoing research on diabetic treatment and high market potential are expected to create opportunities in the oral anti-diabetes market in the near future.

In terms of drug class, the global oral anti-diabetes drug market has been segmented into five types: alpha-glucosidase inhibitors, meglitinides, sulfonylureas, biguanides, and others. The biguanides derivatives and sulphonylureas segments are expected to account for major shares of the global oral anti-diabetes drug market.

Oral Anti-diabetes Drugs Market: Region-wise Outlook

In terms of region, the global oral anti-diabetes drugs market has been segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America dominates the global oral anti-diabetes drugs market, followed by Europe, owing to the introduction of new products and presence of favorable government initiatives for oral anti-diabetes drugs in the region. Asia Pacific is expected to witness the fastest growth in the near future attributed to increase geriatric population in the region.

Request Brochure of the Report:
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=23162

Oral Anti-diabetes Drugs Market: Key Players

Major players operating in the global oral anti-diabetes drugs market are Eli Lilly, Abbott, Biocon, Sanofi, Sunpharma, Novartis, Novo Nordisk, Merck, GlaxoSmithKline, Piramal Healthcare, Bristol-Myers Squibb, Bayer Healthcare, Dr. Reddy’s Laboratories Ltd, and Pfizer. Increasing competition among key players is expected to drive the global oral anti-diabetes drugs market during the forecast period.

About us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Transparency Market Research
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email:
Website: https://www.transparencymarketresearch.com/



# # #


Submitted by hawer on Wednesday, 27 March 2019 at 2:44 AM
Category: Health Care & Medical
 
Related News

Pulmonary Arterial Hypertension Market Is Expected To Drive By Availability Of Several Treatment Opt
Wednesday, 26 Jun 2019

Pain Management Therapeutics Market Is Expected To Drive By Rising Number Of Surgeries
Wednesday, 26 Jun 2019

Organ Preservation Solutions Market Is Expected To Drive By Increasing Technological Developments
Wednesday, 26 Jun 2019

Pulmonary Drug Delivery Devices Market is anticipated to exceed a value of US$28.7 bn by 2019
Wednesday, 26 Jun 2019

Nutraceutical Ingredients Market Is Expected To Drive By Rapidly Increasing Customer Base Across The
Wednesday, 26 Jun 2019

Related Events

LEAP HR Healthcare: Radical Change Through People
Monday, 24 Jun 2019

2nd Combination Products Lifecycle Management 2019
Tuesday, 25 Jun 2019

ISAH 2019: 15th International Conference on SubArachnoid Hemorrhage 2019
Tuesday, 25 Jun 2019

Cell Engager Summit, June 25-27, 2019, Boston, MA
Tuesday, 25 Jun 2019

Proteome- Targeted Drug Discovery Summit 2019
Wednesday, 26 Jun 2019

Latest News

Party Enjoyable With Bounce Houses
Wednesday, 26 Jun 2019

LeoList Announces A Change In Ownership
Wednesday, 26 Jun 2019

EastShore Mining Devices Revolutionizing Cryptocurrency Mining
Wednesday, 26 Jun 2019

Pulmonary Arterial Hypertension Market Is Expected To Drive By Availability Of Several Treatment Opt
Wednesday, 26 Jun 2019

Pain Management Therapeutics Market Is Expected To Drive By Rising Number Of Surgeries
Wednesday, 26 Jun 2019

 
Want to get your press releases, event listings, and job ads on Scoopasia? Register now for a FREE account or login if you already have one!
Scoopasia v1.0b. Copyright © 2019
Today is Wednesday, 26 June 2019

About Scoopasia | FAQ | Privacy Policy | Contact Us

Press Releases
Event Listings
Job Listings
Arts & Entertainment
Architecture & Construction
Automotive & Travel
Business
Consumer Technology
Economy
Education
Enterprise Technology
Food & Fashion
Government & Policy
Health Care & Medical
Legal/Law
News & Media
Religion
Science & Research
Sports & Fitness
Login / Register
Get Scoopasia through RSS Feeds & Email Notifications!


Journalist's Toolbox
Hello journalist, welcome to Scoopasia--a powerful online resource for media information in Asia. Scoopasia has press releases and media events for every beat and industry. All content on Scoopasia is 100% FREE. You don't even need to login!

  • Scoop Line
    (Instant Information Request)
    The easiest way to ask questions and request information from the PR community.


  • Advanced Search
    Drill down, dig deep, for media information the way you want it.

  • Journalist's Resources
    Resources and tools you can't do without.

  • PR Tools
    Scoopasia Blog Search
    Search the largest handpicked collection of Asia's most prominent and influential blogs.


    Resources
  • PR Bookmarks
  • Web 2.0 Bookmarks
  • Media Bookmarks

    More Coming Soon...

  • Upcoming Events
  • LEAP HR Healthcare: Radical Change Through People
  • 2nd Combination Products Lifecycle Management 2019
  • Transition from IBOR to Risk Free Rates | London, 25 - 26 June 2019
  • Palo Alto Networks: Networking breakfast
  • Women of Silicon Roundabout - Join 6,000+ women in tech this June in London

  • Latest Jobs
    Sorry, there are currently no entries posted here.